Percentage of free to total PSA as a biomarker of survival in metastatic castration-resistant prostate cancer.
To analyse whether the percentage of free to total prostate-specific antigen (%fPSA) is a prognostic biomarker in metastatic castration-resistant prostate cancer (mCRPC), as novel studies suggest an elevated %fPSA is associated with adverse oncological …